1. I had breast cancer – but now I feel healthy and my aftercare has been unremarkable recently – do I belong to the risk group?
The answer is no.
Women after breast cancer are not more likely to develop infectious diseases. They are now just as healthy as their neighbour and should feel that way.
2. This also applies to women who have undergone a chemotherapy in the past. Their immune system was only limited by the chemotherapy for a short period of time – usually you can assume that with the recovery of the white blood cells (leukocytes) a regular immune defense is present.
3. I am taking an anti-hormonal therapy – am I at risk?
no – women under or after a anti-hormonal therapy (e.g. Tamoxifen/NolvadexÒ, Anastrozol/ArimidexÒ, Letrozol/FemaraÒ, Exemestane/AromasinÒ, Faslodex/FulvestrantÒ) are no longer at risk.
4. I have finished my chemotherapy and receive infusions with antibodies (e.g. Trastuzumab/HerzeptinÒ or Pertuzumab/PerjetaÒ):
no – – as long as your blood count has recovered from the chemotherapy, there is no increased risk.
5. Who are the women we have to classify as at risk?
a) Patients who are currently receiving a chemotherapy.
b) Patients who are taking so-called CDK4/6 inhibitors (Palbociclib/IbranceÒ, Ribociclib/ KisqaliÒ, Abemaciclib/VerceniosÒ)
c) Patients with advanced illnesses who require long-term therapy – e.g. Everolimus/AfinitorÒ, Alpelisib/PicrayÒ, cortisone preparations.
Patients who fall under category 5: please contact your treating oncologist. You will find further information under:
https://www.krebsliga.ch/beratung-unterstuetzung/coronavirus-wir-sind-fuer-sie-da-in-dieser-krise-erst-recht/
